User Fee Delinquencies Rising At US FDA After PDUFA Redesign
Prescription drug user fee "receivables" nearly doubled in FY 2018, but the US FDA is not worried.
Prescription drug user fee "receivables" nearly doubled in FY 2018, but the US FDA is not worried.